Spotlight
Twitter feed
Now available: Our newly updated guideline on selection of optimal adjuvant chemo and targeted therapy for #breastcancer https://t.co/Tpg2OKyaAC @ndenduluri1 et al #bcsm #breastcancerawareness
We're accepting applications from U.S. med schools to participate in our Oncology Scholars Rotation pilot program, an immersive program for rising 2nd yr med students from #URiM populations. Apply by Nov. 2 ⬇️ https://t.co/jSHqGQaWOG #MedStudentTwitter #MedTwitter
Congratulations to Leah Schmidt, PhD, one of the recipients of the 2020 AACR-AstraZeneca Immuno-oncology Research Fellowship. We look forward to her findings on obstacles associated with T cell therapy in lung cancer and potential strategies for safely enhancing ACT efficacy.
We invite applications for the 2021 Breast Cancer Research Foundation-AACR Career Development Awards to Promote Diversity and Inclusion. These two-year, $150,000 grants support projects investigating innovative approaches to breast cancer treatment:
https://t.co/tvIItBJ79Q
“Lives will be saved,” said Kimmie Ng, MD (@ng_kimmie), as the U.S. Preventive Services Task Force recommends that adults should start screening for colorectal cancer at age 45, instead of waiting until 50: https://t.co/BnQGRrXye1 via @RoniNYTimes @NYTHealth #crc
We congratulate Maria Casanova-Acebes, PhD, one of the recipients of the 2020 AACR-AstraZeneca Immuno-oncology Research Fellowship. We look forward to her findings on the functional contribution of macrophage subsets on tumor growth and immunotherapy response of lung cancers.
Due Oct 30:
Competitive Letters of Intent are invited from #Fellows for the AACR-John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship. The fellowship provides $120,000 over two years to support mentored basic cancer research.
https://t.co/j4r65vlsgC
New #JCOCCI article details the process of how #CancerLinQ ingests #EHR data. https://t.co/7bN8WVK82C
“If you look at all types of cancer survivors as a group, certainly endocrinopathies are among the most common late effects, occurring in at least 40% to 50% of children,” Laurie Cohen, MD, of @DFBC_PedCare told @GoHealio:
Pediatric cancer survivors often face endocrine, cardiometabolic issues later in life
Children with cancer are particularly vulnerable to the adverse effects of treatments such as chemotherapy, radiation and hematopoietic stem cell tran...
ms.spr.ly
DYK: 64% of Americans report having a cancer screening test delayed or cancelled due to #COVID19. More #ASCOCancerSurvey findings here ➡️ https://t.co/MUNiq3jlAM
Announcements
Donor highlight
Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the development of revolutionary therapies to treat cancer. We are grateful for their vision and incredible support.
